These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28118618)

  • 1. Management of Type 2B von Willebrand Disease during Pregnancy.
    McLaughlin D; Kerr R
    Acta Haematol; 2017; 137(2):89-92. PubMed ID: 28118618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy in type 2B VWD: a case series.
    Ranger A; Manning RA; Lyall H; Laffan MA; Millar CM
    Haemophilia; 2012 May; 18(3):406-12. PubMed ID: 22077376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of patients with Type 2B von Willebrand's disease during delivery and puerperium].
    Güth U; Tsakiris DA; Reber A; Holzgreve W; Hösli I
    Z Geburtshilfe Neonatol; 2002; 206(4):151-5. PubMed ID: 12198592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease.
    Jilma B; Paulinska P; Jilma-Stohlawetz P; Gilbert JC; Hutabarat R; Knöbl P
    Thromb Haemost; 2010 Sep; 104(3):563-70. PubMed ID: 20589313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and therapeutic management in a patient with type 2B-like acquired von Willebrand syndrome.
    Karger R; Weippert-Kretschmer M; Budde U; Kretschmer V
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):144-7. PubMed ID: 21178586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A first Taiwanese Chinese family of type 2B von Willebrand disease with R1306W mutation.
    Shen MC; Lin JS; Lin DS; Hsu SC; Lin B
    Thromb Res; 2003; 112(5-6):291-5. PubMed ID: 15041272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions.
    Golder M; Pruss CM; Hegadorn C; Mewburn J; Laverty K; Sponagle K; Lillicrap D
    Blood; 2010 Jun; 115(23):4862-9. PubMed ID: 20371742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher and lower active circulating VWF levels: different facets of von Willebrand disease.
    Casonato A; Pontara E; Morpurgo M; Sartorello F; De Groot PG; Cattini MG; Daidone V; De Marco L
    Br J Haematol; 2015 Dec; 171(5):845-53. PubMed ID: 26456374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ; van Vliet HH
    Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A family having type 2B von Willebrand disease with an R1306W mutation: Severe thrombocytopenia leads to the normalization of high molecular weight multimers.
    Ozeki M; Kunishima S; Kasahara K; Funato M; Teramoto T; Kaneko H; Fukao T; Kondo N
    Thromb Res; 2010 Feb; 125(2):e17-22. PubMed ID: 19740526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2B or not 2B? A diagnosis of von Willebrand disease a lifetime of 86 years in the making.
    Chapman K; Prasad R; Mohammed S; Favaloro EJ
    Blood Coagul Fibrinolysis; 2021 Apr; 32(3):229-233. PubMed ID: 33443930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia.
    Casonato A; Gallinaro L; Cattini MG; Pontara E; Padrini R; Bertomoro A; Daidone V; Pagnan A
    Haematologica; 2010 Aug; 95(8):1366-72. PubMed ID: 20305138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand disease.
    Jilma-Stohlawetz P; Knöbl P; Gilbert JC; Jilma B
    Thromb Haemost; 2012 Aug; 108(2):284-90. PubMed ID: 22740102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on type 2B von Willebrand disease.
    Mikhail S; Aldin ES; Streiff M; Zeidan A
    Expert Rev Hematol; 2014 Apr; 7(2):217-31. PubMed ID: 24521271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.
    Frontroth JP; Hepner M; Sciuccati G; Feliú Torres A; Pieroni G; Bonduel M
    Thromb Haemost; 2010 Dec; 104(6):1158-65. PubMed ID: 20941465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of type 2b von Willebrand disease in the neonatal period.
    Proud L; Ritchey AK
    Pediatr Blood Cancer; 2017 Jan; 64(1):103-105. PubMed ID: 27468167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudo (platelet-type) von Willebrand disease in pregnancy: a case report.
    Grover N; Boama V; Chou MR
    BMC Pregnancy Childbirth; 2013 Jan; 13():16. PubMed ID: 23327637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidural labor analgesia and parturient with type 2B von Willebrand disease].
    Lagarrigue J; Richez B; Julliac B; Saltel L; Nurden P; Sztark F
    Ann Fr Anesth Reanim; 2013 Jan; 32(1):56-9. PubMed ID: 23218955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2B von Willebrand Disease: Early Manifestation as Neonatal Thrombocytopenia.
    Kranzhöfer D; Pavlova A; Schneider H; Franck P; Glonnegger H; Büchsel M; Yoshimi-Nöllke A; Oldenburg J; Zieger B
    Hamostaseologie; 2021 Dec; 41(6):469-474. PubMed ID: 34942660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.